IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples